Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Cash flows from (used in) operating activities:        
Net loss for the period $ (11,333) $ (13,249) $ (41,030) $ (40,525)
Items not involving cash:        
Stock-based compensation 1,828 4,905 10,635 17,007
Depreciation and amortization 36 37 106 115
Amortization of right-of-use assets 119 116 353 345
Interest on lease liabilities 10 17 35 54
Unrealized foreign exchange (loss)/gain 4 0 (1) 9
Accrued interest on investments (3) 9 (5) 22
Change in non-cash operating working capital:        
Prepaid expenses 788 (83) 1,520 (81)
Other assets 10 2 (2) 26
Operating lease payments (139) (136) (416) (401)
Account payable (1,284) (374) (541) (431)
Accrued liabilities 1,905 486 2,086 320
Cash used in operating activities (8,059) (8,270) (27,260) (23,540)
Cash flows from (used in) financing activities:        
Issuance of common shares pursuant to Public Offering, net of broker commission and agent legal fees 0 58,234 0 58,234
Issuance of common shares upon exercise of stock options 0 49 160 531
Cash provided by financing activities 0 58,283 160 58,765
Cash flows from (used in) investing activities:        
Maturity (acquisition) of investments, net (4) (4,398) (15,000) (15,278)
Purchase of property and equipment (181) 0 (198) (53)
Cash provided by (used in) investing activities (185) (4,398) (15,198) (15,331)
Effect of exchange rate fluctuations on cash and cash equivalents held (4) 0 0 (9)
Decrease in cash and cash equivalents (8,248) 45,615 (42,298) 19,885
Cash and cash equivalents, beginning of period 83,343 54,112 117,393 79,842
Cash and cash equivalents, end of period $ 75,095 $ 99,727 $ 75,095 $ 99,727